Loading...
XJPX
6523
Market cap809mUSD
Jul 10, Last price  
1,051.00JPY
1D
1.15%
1Q
-2.32%
IPO
-60.93%
Name

PHC Holdings Corp

Chart & Performance

D1W1MN
XJPX:6523 chart
P/E
270.26
P/S
0.36
EPS
3.89
Div Yield, %
4.04%
Shrs. gr., 5y
0.82%
Rev. gr., 5y
3.55%
Revenues
364.40b
+0.78%
186,546,000,000272,637,000,000306,071,000,000340,452,000,000356,434,000,000353,900,000,000361,593,000,000364,403,000,000
Net income
492m
-95.31%
15,453,000,0005,277,000,00016,906,000,000-8,460,000,000-3,221,000,000-12,892,000,00010,484,000,000492,000,000
CFO
42.46b
+1.23%
33,790,000,00036,865,000,00047,850,000,00051,053,000,00021,376,000,00041,304,000,00041,941,000,00042,458,000,000
Dividend
Sep 29, 202621 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
IPO date
Oct 14, 2021
Employees
9,403
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT